NACDS: Texas Attorney General Paxton Rules Wisely on State PBM Reform’s Enforceability
NACDS says “flimsy PBM excuses are dwindling, and for Texans and more Americans help is on the way.”
NACDS Lauds Rep. Krishnamoorthi’s Focus on Reforming “PBM Middleman” Tactics That Inflate People’s Drug Costs, Restrict Access to Care, and Close Pharmacies
NACDS issued a statement about an event in Chicago where the Congressman will discuss the latest Federal Trade Commission report about PBM middlemen’s tactics.
CNBC’s Cramer: “If [President Trump] wants to put a stake in inflation, he goes after the pharmacy benefit managers”
January 22 Squawk on the Street highlights need for PBM reform, a key piece of NACDS’ “Four Wins to Make America Healthy Again”
In December, President Trump pledged to take on the middlemen in two national TV appearances in one week
NACDS Issues Recommendations to Trump Administration: Four Wins to Make America Healthy Again
“This is an important moment to fix lingering and devastating problems and to leverage tremendous opportunities for Americans and for the pharmacies and pharmacists who serve them.”
Unanimously, FTC Issues Second Pounding of Big PBMs
NACDS: “The problems of big-PBM tactics remain obvious. The bipartisan and broadly-backed solutions remain ready in Congress. Time is wasting – as is Americans’ money. It’s time to stop this rip-off and to deliver a win for the American people.”
NACDS Statement Calls on FTC to Continue to “Shine the Light” on Harmful Practices of PBM Middlemen
NACDS’ all-levels and all-branches of government approach to PBM reform prioritizes the enactment, implementation, enforcement, and oversight of reforms.
NACDS Hails Momentum for PBM Reform at the State Level Heading into 2025
Arkansas and Massachusetts are the latest states to hold PBMs accountable, help preserve patient access to the medications right for them.
In 2024 alone, 24 states enacted 33 bills, leading to adoption of 74 policy changes that align with NACDS’ PBM reform and reimbursement priorities; more than 131 new state PBM reform laws were enacted from 2021-2023.
NACDS Lauds Congress for CR Negotiations, Declares “Key Votes” in House and Senate to Secure PBM Reforms Crucial for Americans and Their Pharmacies
By finishing this job, Congress would turn momentum into results and make the “most significant federal progress ever in addressing PBMs’ ‘pharmaceutical benefit manipulation’”
In Case You Missed It: President-Elect Trump Affirms Commitment to PBM Reform in Two National Media Events in One Week
At a news conference today at Mar-a-Lago, President-elect Donald Trump said the following:
“We are paying far too much, because we are paying far more than other countries. We have laws that make it impossible to reduce [drug costs] and we have a thing called a ‘middleman’ … that makes more money than the drug companies, and they don’t do anything except they’re middlemen. We are going to knock out the middleman.” WATCH THE CLIP
Trump’s statement today follows his remarks on December 8 during an interview on Meet the Press:
“We’re going to do a lot of things. Number one, we’re going to reduce prices – because the middleman makes more money than the drug companies in all fairness to the drug companies. There’s a middleman that nobody even knows who they are.” WATCH THE CLIP MORE PBM REFORM NEWS
Pharmacy Groups to “Key Vote” Continuing Resolution with Real PBM Reforms
“Yes” on CR with specific Medicaid and Medicare reforms is essential to confront PBM tactics that inflate American’s prescription drug costs, force pharmacy closures, and block access to Americans’ pharmacies of choice
